Back to Table of contents

Primeur weekly 2019-03-18

Focus

e-Infrastructures and HPC Knowledge Base gets a new look ...

Quantum computing

Physicists 'reverse time' using quantum computer ...

ASC X9 publishes white paper and technical report on quantum computing risks; new quantum standard effort announced ...

Focus on Europe

ARCHER2 92 million euro supercomputer set to boost UK capability ...

Slovak Government provides capital infusion of 15 million euro to Tachyum ...

Director eScience Center takes on new challenge ...

e-IRG issues Call for Participation to first Open Workshop in 2019 under Romanian EU Presidency ...

Middleware

WekaIO strengthens oil and gas industry presence with new Houston office ...

Hardware

Excelero awarded another patent for heightened NVMe storage efficiency ...

Submer launches SmartPodX, the world's first green OCP and hyperscale-ready Immersion Cooling solution ...

Handling trillions of supercomputer files just got simpler ...

Arm, Cadence and Xilinx introduce first Arm Neoverse system development platform for next-generation Cloud-to-Edge infrastructure, implemented on TSMC 7nm process technology ...

Applications

Promising diagnostics for detecting latent tuberculosis revealed ...

38 Illinois research groups awarded time on Blue Waters leadership supercomputer ...

Nicholas Nystrom named PSC Chief Scientist ...

Physicists use supercomputers to solve 50-year-old beta decay puzzle ...

New method opens the way for cutting tools with longer lifetime ...

Artificial intelligence speeds up ...

UC San Diego study points to virus-related acceleration in some cancers ...

The Cloud

Mellanox introduces breakthrough NVMe SNAP technology to simplify composable storage ...

Wiwynn showcases immersion cooling solutions at OCP Global Summit 2019 ...

UC San Diego study points to virus-related acceleration in some cancers


This Venn diagram depicts the common significant pathways in all four cancers: HTLV-1 infection, pathways in cancer, pancreatic cancer pathway, chronic myeloid leukemia pathway, and bladder cancer pathway. Image credit: Steven Chen, SDSC/REHS.
14 Mar 2019 San Diego - While the human T-cell leukemia virus type 1 (HTLV-1) is known to cause a rare cancer of the immune system's T-cells called adult T-cell leukemia or ATL in about five percent of those infected, researchers from the San Diego Supercomputer Center (SDSC) and Moores Cancer Center at UC San Diego recently hypothesized that this virus, as well as another lesser-known "cousin" called bovine leukemia virus (BLV), may also play a role in the accelerated development of breast cancer, esophageal cancer, pancreatic cancer, and glioblastoma (brain/spinal cancer).

In aJournal of Cancer Research and Therapypaper published last month called " HTLV-1 Can Be Involved in Acceleration of Different Nonhematological Cancers ", Valentina Kouznetsova, Steven Chen, and Igor Tsigelny proposed the necessity of studies related to HTLV-1 and BLV affecting other cancers. Valentina Kouznetsova is a researcher affiliated with SDSC and on staff at the Moores Cancer Center, while Igor Tsigelny is affiliated with both SDSC and Moores. Steven Chen participated on the research team via the SDSC's Research Experience for High School Students (REHS) summer internship programme.

"One of our interesting findings was that HTLV-1 infected patients in southern Japan without any manifestations of ATL-developed various cancers correlated with the possible HTLV-1 proteins influencing a set of cancer pathways equivalent to cancerogenic mutations", stated Valentina Kouznetsova, the lead author of the study.

"This problem is not easy", added Igor Tsigelny. "To assume that HTLV-1 virus proteins affect different cancers, one of the assumptions would have to be that the virus may spread from T-cells where it usually lives, to other types of cells. It is not obvious how that happens, but a number of anecdotal evidences show that HTLV-1 affects various cancers, not only leukemia. It is possible that other mechanisms also are involved."

Similarly, BLV is spread from infected cattle to non-infected cattle by direct contact or exposure to blood. While BLV is not believed to survive pasteurization, the virus has the potential to be transmitted from an infected cow's raw milk to a human. Likewise, the virus may also be able to be transmitted from an infected cow's undercooked meat to humans. While the cattle industry strives to keep infected cattle segregated from healthy cattle, several studies have found BLV in breast cancer tumours.

According to researchers at Michigan State University (MSU), as of 2018 BLV was prevalent in about 43 percent of all U.S. cattle. However, BLV has been completely eradicated in more than 20 nations, most of which are in Europe, and their efforts can be used as models for implementing several control strategies. Large Animal Clinical Sciences Professor Paul Bartlett at MSU is currently conducting several field trials in which the most infectious cattle are culled or segregated to reduce transmission.

"Other approaches involve controlling biting flies and implementing various management controls to reduce blood-borne transmission", stated Paul Bartlett. "Most of our earlier work involved documenting the specific ways in which BLV disrupts the bovine immune system and discovering the unexpectedly large impact on milk production and dairy cow lifespan."

While efforts to eradicate BLV in cattle are important by themselves, the research done to date by Valentina Kouznetsova, Steven Chen, and Igor Tsigelny have the potential to eventually mitigate multiple cancers' acceleration caused by those infections.

Igor Tsigelny, along with his work at UC San Diego, is the Chief Science Officer and co-founder of CureMatch, a company which provides decision support for doctors in personalized cancer medicine. "With 4.5 million possibilities to combine around 300 FDA-approved cancer drugs, CureMatch targets multiple cancer mutations at the same time and determines the best combination treatment for each patient", explained Igor Tsigelny. "While this study is not related to the current tasks of CureMatch, it may become so in the future."

SDSC Director Michael Norman is a member of the CureMatch Advisory Board. No grant funding was used for this study.
Source: San Diego Supercomputer Center - SDSC

Back to Table of contents

Primeur weekly 2019-03-18

Focus

e-Infrastructures and HPC Knowledge Base gets a new look ...

Quantum computing

Physicists 'reverse time' using quantum computer ...

ASC X9 publishes white paper and technical report on quantum computing risks; new quantum standard effort announced ...

Focus on Europe

ARCHER2 92 million euro supercomputer set to boost UK capability ...

Slovak Government provides capital infusion of 15 million euro to Tachyum ...

Director eScience Center takes on new challenge ...

e-IRG issues Call for Participation to first Open Workshop in 2019 under Romanian EU Presidency ...

Middleware

WekaIO strengthens oil and gas industry presence with new Houston office ...

Hardware

Excelero awarded another patent for heightened NVMe storage efficiency ...

Submer launches SmartPodX, the world's first green OCP and hyperscale-ready Immersion Cooling solution ...

Handling trillions of supercomputer files just got simpler ...

Arm, Cadence and Xilinx introduce first Arm Neoverse system development platform for next-generation Cloud-to-Edge infrastructure, implemented on TSMC 7nm process technology ...

Applications

Promising diagnostics for detecting latent tuberculosis revealed ...

38 Illinois research groups awarded time on Blue Waters leadership supercomputer ...

Nicholas Nystrom named PSC Chief Scientist ...

Physicists use supercomputers to solve 50-year-old beta decay puzzle ...

New method opens the way for cutting tools with longer lifetime ...

Artificial intelligence speeds up ...

UC San Diego study points to virus-related acceleration in some cancers ...

The Cloud

Mellanox introduces breakthrough NVMe SNAP technology to simplify composable storage ...

Wiwynn showcases immersion cooling solutions at OCP Global Summit 2019 ...